Silencing and nuclear repositioning of the λ5 gene locus at the pre-B cell stage requires Aiolos and OBF-1

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Karnowski, Alexander ^a,b   Cao, Chun ^a   Matthias, Gabriele ^a   Carotta, Sebastian ^b   Corcoran, Lynn M ^b   Martensson, Inga Lill ^c   Skok, Jane A ^d,e   Matthias, Patrick ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AIOLOS; TRANSCRIPTION FACTOR OBF 1; UNCLASSIFIED DRUG; POU2AF1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; ZFPN1A3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL COUNT; CELL MATURATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE REARRANGEMENT; GENE SILENCING; IMMUNOGLOBULIN LIGHT CHAIN GENE; MOUSE; MOUSE MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; TRANSCRIPTION REGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE ORDER; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ORDER; GENE REARRANGEMENT, B-LYMPHOCYTE, LIGHT CHAIN; GENE SILENCING; IMMUNOGLOBULIN LAMBDA-CHAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELLS, B-LYMPHOID; TRANS-ACTIVATORS;

EID: 55849092079     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003568     Document Type: Article

References (72)

1. Busslinger M (2004) Transcriptional control of early B cell development. Annu Rev Immunol 22: 55-79.
2. Johnson K, Shapiro-Shelef M, Tunyaplin C, Calame K (2005) Regulatory events in early and late B-cell differentiation. Molecular Immunology 42: 749.
3. Matthias P, Rolink AG (2005) Transcriptional networks in developing and mature B cells. Nature Reviews Immunology 5: 497.
4. Hendriks RW, Middendorp S (2004) The pre-BCR checkpoint as a cell-autonomous proliferation switch. Trends in Immunology 25: 249.
5. ten Boekel E, Yamagami T, Andersson J, Rolink AG, Melchers F (1999) The formation and selection of cells expressing preB cell receptors and B cell receptors. Curr Top Microbiol Immunol 246: 3-9; discussion 9-10.
6. Melchers F (2005) The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat Rev Immunol 5: 578-584.
7. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, et al. (2001) Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167: 6834-6840.
8. Loder F, Mutschler B, Ray RJ, Paige CJ, Sideras P, et al. (1999) B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 190: 75-89.
9. Rolink AG, Andersson J, Melchers F (1998) Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol 28: 3738-3748.
10. Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, et al. (2001) The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14: 603-615.
11. Gstaiger M, Georgiev O, van Leeuwen H, van der Vliet P, Schaffner W (1996) The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. Embo J 15: 2781-2790.
12. Luo Y, Roeder RG (1995) Cloning, functional characterization, and mechanism of action of the B- cell-specific transcriptional coactivator OCA-B. Mol Cell Biol 15: 4115-4124.
13. Strubin M, Newell JW, Matthias P (1995) OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80: 497-506.
14. Hess J, Werner A, Wirth T, Melchers F, Jack HM, et al. (2001) Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. Proc Natl Acad Sci U S A 98: 1745-1750.
15. Schubart DB, Rolink A, Schubart K, Matthias P (2000) Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. J Immunol 164: 18-22.
16. Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P (1996) B-cellspecific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature 383: 538-542.
17. Kim U, Qin XF, Gong S, Stevens S, Luo Y, et al. (1996) The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 383: 542-547.
18. Bartholdy B, Du Roure C, Bordon A, Emslie D, Corcoran LM, et al. (2006) The Ets factor Spi-B is a direct critical target of the coactivator OBF-1. Proc Natl Acad Sci U S A 103: 11665-11670.
19. Corcoran LM, Hasbold J, Dietrich W, Hawkins E, Kallies A, et al. (2005) Differential requirement for OBF-1 during antibody-secreting cell differentiation. J Exp Med 201: 1385-1396.
20. Samardzic T, Gerlach J, Muller K, Marinkovic D, Hess J, et al. (2002) CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice. Eur J Immunol 32: 2481-2489.
21. Sun J, Matthias G, Mihatsch MJ, Georgopoulos K, Matthias P (2003) Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice. J Immunol 170: 1699-1706.
22. Samardzic T, Marinkovic D, Nielsen PJ, Nitschke L, Wirth T (2002) BOB.1/ OBF.1 Deficiency Affects Marginal-Zone B-Cell Compartment. Mol Cell Biol 22: 8320-8331.
23. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, et al. (1997) Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. Embo J 16: 2004-2013.
24. Georgopoulos K (1997) Transcription factors required for lymphoid lineage commitment. Curr Opin Immunol 9: 222-227.
25. Kim J, Sif S, Jones B, Jackson A, Koipally J, et al. (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10: 345-355.
26. Koipally J, Renold A, Kim J, Georgopoulos K (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. Embo J 18: 3090-3100.
27. Wang JH, Avitahl N, Cariappa A, Friedrich C, Ikeda T, et al. (1998) Aiolos regulates B cell activation and maturation to effector state. Immunity 9: 543-553.
28. Liu W, Saint DA (2002) Validation of a quantitative method for real time PCR kinetics. Biochemical and Biophysical Research Communications 294: 347-353.
29. Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, et al. (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochemical and Biophysical Research Communications 313: 856-862.
30. Simon P (2003) Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 19: 1439-1440.
31. Schlissel MS, Baltimore D (1989) Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 58: 1001-1007.
32. Bertolino E, Reddy K, Medina KL, Parganas E, Ihle J, et al. (2005) Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene re-arrangements by transcription factor STAT5. Nat Immunol 6: 836-843.
33. Roldan E, Fuxa M, Chong W, Martinez D, Novatchkova M, et al. (2005) Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat Immunol 6: 31-41.
34. Parker MJ, Licence S, Erlandsson L, Galler GR, Chakalova L, et al. (2005) The pre-B-cell receptor induces silencing of VpreB and lambda5 transcription. Embo J.
35. Holmes ML, Carotta S, Corcoran LM, Nutt SL (2006) Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment. Genes Dev 20: 933-938.
36. Kim U, Siegel R, Ren X, Gunther CS, Gaasterland T, et al. (2003) Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses. PNAS 100: 8868-8873.
37. Laumen H, Brunner C, Greiner A, Wirth T (2004) Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator. Nucl Acids Res 32: 1577-1583.
38. Thompson EC, Cobb BS, Sabbattini P, Meixlsperger S, Parelho V, et al. (2007) Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26: 335-344.
39. Lu R, Medina KL, Lancki DW, Singh H (2003) IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev 17: 1703-1708.
40. Hoffmann R, Seidl T, Neeb M, Rolink A, Melchers F (2002) Changes in Gene Expression Profiles in Developing B Cells of Murine Bone Marrow. Genome Res 12: 98-111.
41. Brouns GS, Vries Ed, Neefjes JJ, Borst J (1996) Assembled Pre-B Cell Receptor Complexes Are Retained in the Endoplasmic Reticulum by a Mechanism That Is Not Selective for the Pseudo-light Chain. J Biol Chem 271: 19272-19278.
42. Wang YH, Nomura J, Faye-Petersen OM, Cooper MD (1998) Surrogate light chain production during B cell differentiation: differential intracellular versus cell surface expression. J Immunol 161: 1132-1139.
43. Flemming A, Brummer T, Reth M, Jumaa H (2003) The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol 4: 38-43.
44. Sigvardsson M, O'Riordan M, Grosschedl R (1997) EBF and E47 Collaborate to Induce Expression of the Endogenous Immunoglobulin Surrogate Light Chain Genes. Immunity 7: 25.
45. Sabbattini P, Lundgren M, Georgiou A, Chow C, Warnes G, et al. (2001) Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. Embo J 20: 2812-2822.
46. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, et al. (2002) PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18: 333-334.
47. Szutorisz H, Canzonetta C, Georgiou A, Chow CM, Tora L, et al. (2005) Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage. Mol Cell Biol 25: 1804-1820.
48. Brown KE, Baxter J, Graf D, Merkenschlager M, Fisher AG (1999) Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol Cell 3: 207-217.
49. Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, et al. (1997) Association of Transcriptionally Silent Genes with Ikaros Complexes at Centromeric Heterochromatin. Cell 91: 845.
50. Skok JA, Brown KE, Azuara V, Caparros ML, Baxter J, et al. (2001) Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat Immunol 2: 848-854.
51. Rolink AG, Winkler T, Melchers F, Andersson J (2000) Precursor B Cell Receptor-dependent B Cell Proliferation and Differentiation Does Not Require the Bone Marrow or Fetal Liver Environment. J Exp Med 191: 23-32.
52. Jumaa H, Mitterer M, Reth M, Nielsen P (2001) The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. European Journal of Immunology 31: 2164-2169.
53. Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M, et al. (1999) Abnormal Development and Function of B Lymphocytes in Mice Deficient for the Signaling Adaptor Protein SLP-65. Immunity 11: 547-554.
54. Middendorp S, Dingjan GM, Hendriks RW (2002) Impaired Precursor B Cell Differentiation in Bruton's Tyrosine Kinase-Deficient Mice. J Immunol 168: 2695-2703.
55. Wen R, Chen Y, Schuman J, Fu G, Yang S, et al. (2004) An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. Embo J 23: 4007-4017.
56. Zou X, Piper TA, Smith JA, Allen ND, Xian J, et al. (2003) Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain. J Immunol 170: 1354-1361.
57. Brunner C, Wirth T (2006) Btk expression is controlled by Oct and BOB.1/ OBF.1. Nucleic Acids Res 34: 1807-1815.
58. Ma S, Pathak S, Trinh L, Lu R (2008) Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood 111: 1396-1403.
59. Friedl EM, Matthias P (1996) Mapping of the transcriptional repression domain of the lymphoid-specific transcription factor oct-2A. J Biol Chem 271: 13927-13930.
60. Lillycrop KA, Dawson SJ, Estridge JK, Gerster T, Matthias P, et al. (1994) Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein. Mol Cell Biol 14: 7633-7642.
61. Malin S, Linderson Y, Almqvist J, Ernberg I, Tallone T, et al. (2005) DNA-dependent conversion of Oct-1 and Oct-2 into transcriptional repressors by Groucho/TLE. Nucl Acids Res 33: 4618-4625.
62. Sabbattini P, Dillon N (2005) The [lambda]5-VpreB1 locus-a model system for studying gene regulation during early B cell development. Seminars in Immunology 17: 121-127.
63. O'Riordan M, Grosschedl R (1999) Coordinate Regulation of B Cell Differentiation by the Transcription Factors EBF and E2A. Immunity 11: 21-31.
64. Cobb BS, Morales-Alcelay S, Kleiger G, Brown KE, Fisher AG, et al. (2000) Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 14: 2146-2160.
65. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, et al. (1995) Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81: 41-51.
66. Mundt C, Licence S, Maxwell G, Melchers F, Martensson IL (2006) Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells. Int Immunol 18: 163-172.
67. Lacorazza HD, Porritt HE, Nikolich-Zugich J (2001) Dysregulated Expression of Pre-T{alpha} Reveals the Opposite Effects of Pre-TCR at Successive Stages of T Cell Development. J Immunol 167: 5689-5696.
68. van den Brandt J, Kwon SH, Hunig T, McPherson KG, Reichardt HM (2005) Sustained pre-TCR expression in Notch1IC-transgenic rats impairs T cell maturation and selection. J Immunol 174: 7845-7852.
69. van Loo PF, Dingjan GM, Maas A, Hendriks RW (2007) Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling. Immunity 27: 468-480.
70. Martin DA, Lu L, Cascalho M, Wu GE (2007) Maintenance of surrogate light chain expression induces developmental delay in early B cell compartment. J Immunol 179: 4996-5005.
71. Casellas R, Jankovic M, Meyer G, Gazumyan A, Luo Y, et al. (2002) OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin kappa genes. Cell 110: 575-585.
72. Edry E, Melamed D (2004) Receptor editing in positive and negative selection of B lymphopoiesis. J Immunol 173: 4265-4271.